Analysis of recombinant mycobacteria as T helper type 1 vaccines in an allergy challenge model
- 1 April 2001
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 102 (4) , 441-449
- https://doi.org/10.1046/j.1365-2567.2001.01207.x
Abstract
The potential for development of mycobacteria as T helper type 1 (Th1) vaccines capable of induction of Th1 responses to recombinant antigens was explored in a model system based on an immunodominant peptide from house dust mite. Different recombinant mycobacterial preparations were compared for their ability to induce a Th1 response to the peptidea. It was found that mycobacterial viability was not a prerequisite for Th1 immunogenicity. A dominant interferon-γ (IFN-γ) response to peptide was observed in splenocytes from C57BL/6J mice immunized with live or heat-killed preparations of recombinant Mycobacterium vaccae or with live attenuated bacillus Calmette–Guèrin (BCG) vaccine expressing the antigen. Interleukin-5 (IL-5), a marker of a Th2 response, was detected only in mice receiving live M. vaccae. A similar pattern was observed in BALB/b mice, although the magnitude of the IFN-γ response was much lower. Control and immunized mice were subsequently exposed to allergen using a Th2-inducing challenge protocol. A significant shift from a Th2 to a Th1 response was observed in immunized mice, as judged by cytokine expression by splenocytes and by subclass of circulating antibody. The effect was seen in three inbred mouse strains differing in their innate bias towards Th1 or Th2 responses. It was dependent on the presence of specific antigen in the mycobacterial preparation and, under the immunization conditions tested, was more pronounced with dead M. vaccae than with live BCG as carrier vaccine. The results demonstrate the potency of killed mycobacteria as Th1 adjuvants and suggest a potential application for recombinant mycobacteria in antigen-specific immune modulation.Keywords
This publication has 51 references indexed in Scilit:
- Infection of Mice with Mycobacterium bovis–Bacillus Calmette-Guérin (BCG) Suppresses Allergen-induced Airway EosinophiliaThe Journal of Experimental Medicine, 1998
- Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-γ production in CD4+ T cellsJournal of Allergy and Clinical Immunology, 1997
- Prediction of murine MHC class I epitopes in a major house dust mite allergen and induction of T1-type CD8+ T cell responsesInternational Immunology, 1997
- Infections and the development of allergyToxicology Letters, 1996
- Induction of T cell responses to the invariant chain derived peptide CLIP in mice immunized with the group 1 allergen of house dust miteInternational Immunology, 1996
- In Th2‐biased lymphatic filarial patients, responses to purified protein derivative of Mycobacterium tuberculosis remain Th1European Journal of Immunology, 1996
- A potential vaccine strategy for asthma and allied atopic diseases during early childhoodThe Lancet, 1994
- Sequence Polymorphisms of cDNA Clones Encoding the Mite Allergen Der p IInternational Archives of Allergy and Immunology, 1993
- Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccinesNature, 1991
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970